GLP1R and cardiac hypertrophy: However, all of these alterations were counteracted after AMPKα was blocked by compound C or the GLP-1 receptor was knocked down, implying that the protective roles of geniposide on cardiac hypertrophy were mediated by the GLP-1 receptor/AMPKα signaling pathway [17] (Figure 5).